Ana Rita Brochado
Ana Rita Brochado
Tübingen University, Germany
Verified email at - Homepage
Cited by
Cited by
Extensive impact of non-antibiotic drugs on human gut bacteria
L Maier, M Pruteanu, M Kuhn, G Zeller, A Telzerow, EE Anderson, ...
Nature 555 (7698), 623, 2018
Species-specific activity of antibacterial drug combinations
AR Brochado, A Telzerow, J Bobonis, M Banzhaf, A Mateus, J Selkrig, ...
Nature 559, 259–263, 2018
Improved vanillin production in baker's yeast through in silico design
AR Brochado, C Matos, BL Mĝller, J Hansen, UH Mortensen, KR Patil
Microbial cell factories 9 (1), 1-15, 2010
Fe-S Cluster Biosynthesis Controls Uptake of Aminoglycosides in a ROS-Less Death Pathway
B Ezraty, A Vergnes, M Banzhaf, Y Duverger, A Huguenot, AR Brochado, ...
Science 340 (6140), 1583-1587, 2013
Bioaccumulation of therapeutic drugs by human gut bacteria
M Klünemann, S Andrejev, S Blasche, A Mateus, P Phapale, ...
Nature 597 (7877), 533-538, 2021
Proton Motive Force Disruptors Block Bacterial Competence and Horizontal Gene Transfer
A Domenech, AR Brochado, V Sender, K Hentrich, B Henriques-Normark, ...
Cell host & microbe, 2020
High-throughput approaches to understanding gene function and mapping network architecture in bacteria
AR Brochado, A Typas
Current opinion in microbiology 16 (2), 199-206, 2013
Overexpression of O‐methyltransferase leads to improved vanillin production in baker's yeast only when complemented with model‐guided network engineering
AR Brochado, KR Patil
Biotechnology and Bioengineering, 2012
Impact of Stoichiometry Representation on Simulation of Genotype-Phenotype Relationships in Metabolic Networks
AR Brochado, S Andrejev, CD Maranas, KR Patil
PLOS Computational Biology 8 (11), e1002758, 2012
The first wide‐scale drug repurposing screen using the Prestwick Chemical Library (1200 bioactive molecules) against Neisseria gonorrhoeae identifies high in vitro activity of …
S Foerster, TN Gustafsson, AR Brochado, V Desilvestro, A Typas, ...
Apmis 128 (3), 242-250, 2020
Systematic analysis of drug combinations against Gram-positive bacteria
E Cacace, V Kim, V Varik, M Knopp, M Tietgen, A Brauer-Nikonow, ...
Nature Microbiology, 1-17, 2023
The antiphage defense system CBASS controls resistance and enables killing by antifolate antibiotics in Vibrio cholerae
S Brenzinger, M Airoldi, AJ Ogunleye, AR Brochado
bioRxiv, 2023.02. 27.530311, 2023
The Vibrio cholerae CBASS phage defence system modulates resistance and killing by antifolate antibiotics
S Brenzinger, M Airoldi, AJ Ogunleye, K Jugovic, MK Amstalden, ...
Nature Microbiology, 1-12, 2024
Emergence of community behaviors in the gut microbiota upon drug treatment
S Garcia-Santamarina, M Kuhn, S Devendran, L Maier, M Driessen, ...
bioRxiv, 2023.06. 13.544832, 2023
Model-Guided Identification of Gene Deletion Targets for Metabolic Engineering in Saccharomyces cerevisiae
AR Brochado, KR Patil
Yeast Metabolic Engineering, 281-294, 2014
High-throughput profiling of drug interactions in Gram-positive bacteria
E Cacace, V Kim, M Knopp, M Tietgen, A Brauer-Nikonow, K Inecik, ...
bioRxiv, 2022.12. 23.521747, 2022
Investigating genotype-phenotype relationships in Saccharomyces cerevisiae metabolic network through stoichiometric modeling
AR Brochado
Compounds and pharmaceutical compositions for prevention and/or treatment of dysbiosis and antibacterial antidotes for microbiome-protection
ARG Brochado, A Typas, L Maier, C Goemans, E Cacace
US Patent App. 17/782,654, 2022
Pharmaceutical compositions for prevention and/or/treatment of infections and antibacterial-induced dysfunctions
A Typas, ARG Brochado, S Göttig
US Patent App. 17/048,735, 2021
The system can't perform the operation now. Try again later.
Articles 1–19